Effectiveness of rituximab in reducing relapse among Filipino neuromyelitis optica patients

被引：0
|
作者：
Mandigma, G. [1 ]
Damian, L. [1 ]
机构：
[1] St Lukes Med Ctr, Inst Neurosci, Manila, Philippines
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2019年 / 405卷
关键词：
D O I：
10.1016/j.jns.2019.10.792
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
WCN19-0239
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Impact of rituximab on relapse rate and disability in neuromyelitis optica
    Bedi, Gurdesh S.
    Brown, Andrew D.
    Delgado, Sylvia R.
    Usmani, Nida
    Lam, Byron L.
    Sheremata, William A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2011, 17 (10) : 1225 - 1230
  • [2] Effect of Rituximab on Relapse Rate and Disability in Neuromyelitis Optica (NMO)
    Bedi, Gurdesh S.
    Brown, Andrew
    Delgado, Sylvia
    Usmani, Nida
    Sheremata, William
    [J]. NEUROLOGY, 2009, 72 (11) : A189 - A189
  • [3] Effectiveness of rituximab in neuromyelitis optica: a meta-analysis
    Fulin Gao
    Bingyan Chai
    Cheng Gu
    Ruipeng Wu
    Tong Dong
    Yuping Yao
    Yi Zhang
    [J]. BMC Neurology, 19
  • [4] Effectiveness of rituximab in neuromyelitis optica: a meta-analysis
    Gao, Fulin
    Chai, Bingyan
    Gu, Cheng
    Wu, Ruipeng
    Dong, Tong
    Yao, Yuping
    Zhang, Yi
    [J]. BMC NEUROLOGY, 2019, 19 (1)
  • [5] Impact of Rituximab on Relapse Rate and Disability in a Cohort of Patients with Neuromyelitis Optica from Quito
    Correa Diaz, Edgar P.
    Torres Herran, Germaine E.
    Caiza Zambrano, Francisco
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 118 - 118
  • [6] Impact of Rituximab on relapse rate and disability in an Ecuadorian cohort of patients with neuromyelitis optica spectrum disorders
    Correa-Diaz, Edgar Patricio
    Torres-Herran, Germaine Eleanor
    Zambrano, Joselyn Elizabeth Mino
    Paredes-Gonzalez, Victor
    Caiza-Zambrano, Francisco Jose
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 48
  • [7] Hypothalamic Relapse in Neuromyelitis Optica
    McKenna, Mary Clare
    Bradley, David
    [J]. NEUROLOGY, 2020, 94 (15)
  • [8] Effectiveness of Rituximab and Oral Immunosuppressive Therapies in Neuromyelitis Optica Spectrum Disorder
    Abou, Widad
    Dresser, Laura
    Javed, Adil
    [J]. ANNALS OF NEUROLOGY, 2022, 92 : S138 - S138
  • [9] Efficacy of rituximab in refractory neuromyelitis optica
    Collongues, N.
    Brassat, D.
    Maillart, E.
    Labauge, P.
    Ouallet, J. C.
    Carra-Dalliere, C.
    Moreau, T.
    Bourre, B.
    Papeix, C.
    Brochet, B.
    Audoin, B.
    Vukusic, S.
    de Seze, J.
    Marignier, R.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (07) : 955 - 959
  • [10] Efficacy of rituximab in refractory neuromyelitis optica
    Collongues, N.
    Brassat, D.
    Maillart, E.
    Labauge, P.
    Ouallet, J. -C.
    Carra-Dalliere, C.
    Moreau, T.
    Bourre, B.
    Papeix, C.
    Audoin, B.
    Brochet, B.
    Vukusic, S.
    De Seze, J.
    Marignier, R.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 78 - 79
12345